United States HR 198: Drug Pricing Transparency and Accountability Act

Status: Referred to the Subcommittee on Health. (as of 2024-12-17)

State: United States · Session: 118 · Bill: HR 198

Sponsors: Matthew M. Rosendale

View United States HR 198 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.